LCS
NXTM

Levin Capital Strategies’s NxStage Medical Inc. NXTM Stock Holding History

Levin Capital Strategies’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-21,018
Closed -$586K – 308
2018
Q3 		$586K Buy
21,018
+5,857
+39% +$165K 0.01% 175
2018
Q2 		$423K Sell
15,161
-13,482
-47% -$362K 0.01% 189
2018
Q1 		$712K Buy
+28,643
New +$697K 0.01% 170

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Levin Capital Strategies's NXTM Position: Q4 2018 in Review

Levin Capital Strategies sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 21,018 shares — an estimated $586K sold.

Levin Capital Strategies first reported a position in NXTM in Q1 2018 and held it in 3 quarters. The position peaked at $712K in Q1 2018. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

  • Levin Capital Strategies reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
  • Levin Capital Strategies sold 21,018 NxStage Medical Inc. shares in Q4 2018, an estimated $586K.
  • Levin Capital Strategies first reported a position in NxStage Medical Inc. in Q1 2018 and held it in 3 quarters.
  • Levin Capital Strategies's NxStage Medical Inc. position peaked at $712K in Q1 2018.
  • 172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Levin Capital Strategies's 13F filing for Q4 2018, filed 5 Feb 2019.